Newborn Screening Market to grow at a CAGR of 7.1% from 2021 to 2027.
The global Newborn Screening market gathered revenue around USD 1.0 Billion in 2020 and market is set to grow USD 3.1 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 7.1% during the prediction period 2021 to 2027.Growth in this market is majorly driven by the increasing prevalence of newborn disorders, favourable reimbursement polcies. However, the availability of refurbished products are expected to restrain the growth of this market to certain extent during the forecast period.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Newborn Screening market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Newborn Screening market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Newborn Screening market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America accounted for the largest share of the newborn screening market in 2019
The newborn screening market, by region, has been segmented into North America, Europe, the Asia Pacific, and the Rest of the world (RoW). North America is the largest market for newborn screening, followed by Europe. Growth in the North American market can be attributed to the availability of newborn screening programs, favorable reimbursement policies, and a strong market player presence.
The Asia Pacific is expected to register the highest CAGR during the forecast period. Growth in this region is driven by the large newborn pool, increasing screening rate, and rising awareness regarding early diagnosis.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Newborn Screening Market are:
Major 10 players covered, including: PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), and Medtronic (Ireland), Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies (US), and Recipe Chemicals+Instruments (Germany)
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Product
By Test
By technology
By End user
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Newborn Screening Market, By Product
7.1. Newborn Screening Market, By Product, 2021-2027
7.1.1. Consumables
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. instruments
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Hearing screening instruements
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Pulse oximeters
7.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Newborn Screening Market, By Test
8.1. Newborn Screening Market, By Test, 2021-2027
8.1.1. Dry blood spot tests
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Hearing screening tets
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. CCHD screening tets
8.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Newborn Screening Market, By technology
9.1. Newborn Screening Market, By technology, 2021-2027
9.1.1. Immune assays & enzymatic assays
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Tandem mass spectrometry
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Molecular assays
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Hearing sceening technologies
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Pulse oximetry
9.1.5.1. Market Revenue and Forecast (2016-2027)
9.1.6. Other Technologies
9.1.6.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Newborn Screening Market, By End user
10.1. Newborn Screening Market, By End user, 2021-2027
10.1.1. Clinical Laboratories
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 11.Global Newborn Screening Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.2. Market Revenue and Forecast, By Test (2016-2027)
11.1.3. Market Revenue and Forecast, By technology (2016-2027)
11.1.4. Market Revenue and Forecast, By End user (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.5.2. Market Revenue and Forecast, By Test (2016-2027)
11.1.5.3. Market Revenue and Forecast, By technology (2016-2027)
11.1.5.4. Market Revenue and Forecast, By End user (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.1.6.2. Market Revenue and Forecast, By Test (2016-2027)
11.1.6.3. Market Revenue and Forecast, By technology (2016-2027)
11.1.6.4. Market Revenue and Forecast, By End user (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.2. Market Revenue and Forecast, By Test (2016-2027)
11.2.3. Market Revenue and Forecast, By technology (2016-2027)
11.2.4. Market Revenue and Forecast, By End user (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.5.2. Market Revenue and Forecast, By Test (2016-2027)
11.2.5.3. Market Revenue and Forecast, By technology (2016-2027)
11.2.5.4. Market Revenue and Forecast, By End user (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Product(2016-2027)
11.2.6.2. Market Revenue and Forecast, By Test (2016-2027)
11.2.6.3. Market Revenue and Forecast, By technology (2016-2027)
11.2.6.4. Market Revenue and Forecast, By End user (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.7.2. Market Revenue and Forecast, By Test (2016-2027)
11.2.7.3. Market Revenue and Forecast, By technology (2016-2027)
11.2.7.4. Market Revenue and Forecast, By End user (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.2.8.2. Market Revenue and Forecast, By Test (2016-2027)
11.2.8.3. Market Revenue and Forecast, By technology (2016-2027)
11.2.8.4. Market Revenue and Forecast, By End user (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.2. Market Revenue and Forecast, By Test (2016-2027)
11.3.3. Market Revenue and Forecast, By technology (2016-2027)
11.3.4. Market Revenue and Forecast, By End user (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.5.2. Market Revenue and Forecast, By Test (2016-2027)
11.3.5.3. Market Revenue and Forecast, By technology (2016-2027)
11.3.5.4. Market Revenue and Forecast, By End user (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.6.2. Market Revenue and Forecast, By Test (2016-2027)
11.3.6.3. Market Revenue and Forecast, By technology (2016-2027)
11.3.6.4. Market Revenue and Forecast, By End user (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.7.2. Market Revenue and Forecast, By Test (2016-2027)
11.3.7.3. Market Revenue and Forecast, By technology (2016-2027)
11.3.7.4. Market Revenue and Forecast, By End user (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.3.8.2. Market Revenue and Forecast, By Test (2016-2027)
11.3.8.3. Market Revenue and Forecast, By technology (2016-2027)
11.3.8.4. Market Revenue and Forecast, By End user (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.2. Market Revenue and Forecast, By Test (2016-2027)
11.4.3. Market Revenue and Forecast, By technology (2016-2027)
11.4.4. Market Revenue and Forecast, By End user (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.5.2. Market Revenue and Forecast, By Test (2016-2027)
11.4.5.3. Market Revenue and Forecast, By technology (2016-2027)
11.4.5.4. Market Revenue and Forecast, By End user (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.6.2. Market Revenue and Forecast, By Test (2016-2027)
11.4.6.3. Market Revenue and Forecast, By technology (2016-2027)
11.4.6.4. Market Revenue and Forecast, By End user (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.7.2. Market Revenue and Forecast, By Test (2016-2027)
11.4.7.3. Market Revenue and Forecast, By technology (2016-2027)
11.4.7.4. Market Revenue and Forecast, By End user (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Product (2016-2027)
11.4.8.2. Market Revenue and Forecast, By Test (2016-2027)
11.4.8.3. Market Revenue and Forecast, By technology (2016-2027)
11.4.8.4. Market Revenue and Forecast, By End user (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.2. Market Revenue and Forecast, By Test (2016-2027)
11.5.3. Market Revenue and Forecast, By technology (2016-2027)
11.5.4. Market Revenue and Forecast, By End user (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.5.2. Market Revenue and Forecast, By Test (2016-2027)
11.5.5.3. Market Revenue and Forecast, By technology (2016-2027)
11.5.5.4. Market Revenue and Forecast, By End user (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Product (2016-2027)
11.5.6.2. Market Revenue and Forecast, By Test (2016-2027)
11.5.6.3. Market Revenue and Forecast, By technology (2016-2027)
11.5.6.4. Market Revenue and Forecast, By End user (2016-2027)
Chapter 12. Company Profiles
12.1. PerkinElmer (US)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Demant A/S (Denmark)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Natus Medical (US)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Bio-Rad Laboratories (US)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Danaher Corporation (US)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Medtronic (Ireland)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Chromsystems Instruments & Chemicals GmbH (Germany)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Trivitron Healthcare (India)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Baebies (US)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Recipe Chemicals+Instruments (Germany)
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers